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THE LANCET
Genetic risk factor for unexplained recurrent early pregnancy loss
Willianne L D M Nelen, Eric A P Steegers, Tom K A B Eskes, Henk J Blom
Raised concentrations of plasma homocysteine may result 
from genetic or nutrient-related disturbances in 
homocysteine metabolism. Methylenetetrahydrofolate 
reductase (MTHFR) is responsible for the synthesis of 5- 
methyltetrahydrofolate, the primary methyl donor in the 
conversion of homocysteine to methionine. Homozygosity 
for the 677 C~>T mutation in the M THFR-gene causes 
increased thermolability of M THFR, redistribution of folate- 
derivatives, elevated plasma homocysteine concentrations^1 
and has been reported to be a risk factor for neural tube 
defects,2 and coronary artery disease.3 We determined the 
prevalence of the 677 C-»T mutation in women with 
recurrent early pregnancy loss (REPL) because raised 
plasma homocysteine concentrations are a risk factor for
REPL.
We studied 185 white women with REPL (two or more 
spontaneous consecutive miscarriages before 17 weeks of 
gestation from the same partner) for which no cause was 
found.4 They were compared with 113 unrelated controls, 
acquaintances of women with REPL, matched for age, sex, 
district, and social class. Controls had had at least one 
uncomplicated pregnancy and no spontaneous abortions. All 
participants were screened for the 677 C—»T mutation by 
PCR and subsequent restriction enzyme analysis with 
HiriFI* Written informed consent was obtained from all 
participants.
There was a significant OR (x2) of 3*3 (95% Cl 1*3-10*1) 
in women with REPL comparing the prevalence of the 
homozygous genotype versus the other two genotypes 
(table). Comparing the same women with REPL with a large 
Dutch population-based control group3 a significant OR of 
2*0 with a 95% Cl from 1-2 to 3*2 was found.
Homozygosity for the 677 C—>T mutation in the 
MTHFR-gene is associated with a two to three-fold risk of 
REPL. Improving folate metabolism in these women by folic 
acid supplements may reduce pregnancy loss,
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recurrent early pregnancy loss (REPL) and controls
Fetuin protects the fetus from TNF
Haichao Wang, Minghuang Zhang, Kuniyasu Soda,
Andrew Sama( Kevin J Tracey
Pregnancy has been term ed “nature’s transplant” because 
the fetus is protected from rejection by mother.1 Rejection 
of a transplanted allograft in an immunocompetent host is 
normally m ediated by the macrophage-derived cytokine, 
tum our necrosis factor (T N F );2 excessive production of 
T N F  during pregnancy causes spontaneous abortion.3,4 We 
recently found that spermine, a ubiquitous biogenic amine 
present in large am ounts in the amnion, counter-regulates 
the im m une response by inhibiting the production of T N F  
and other proinflammatory cytokines by human 
m ononuclear cells.5 We have now discovered that a fetal 
plasma glycoprotein* fetuin, is required for the inhibition of 
T N F  production by spermine. Although fetuin was first 
described more than 50 years ago in fetal bovine serum, 
and subsequently found to share high homology to human 
fetuin (a2-HS-glycoprotein), its role in pregnancy and fetal 
development is unknown.
While investigating the mechanism underlying spermine- 
mediated suppression of T N F  production in the murine 
macrophage-like cell line RAW 264.7, we accidentally 
discovered that macrophages lost their responsivity to 
spermine when cultured under low serum conditions. That 
is3 despite the addition of cytokine-suppressing 
concentrations of spermine to these cells, the production of 
T N F  was uninhibited by spermine after stimulation with 
bacterial endotoxin (lipopolysaccharide, LPS). Reasoning 
that these cells had  becom e deprived of a protein that was 
required to inhibit the production of TNF, we added 
fractionated proteins from normal cells and assayed their 
ability to restore sperm ine-dependent inhibition of T N F  
production under serum-free culture conditions. After 
anion-exchange chrom atography and SDS-PAGE gel 
elution5 we isolated a single protein that mediated the 
responsivity of macrophage cultures to spermine. Protein-
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